Hudson Valley Investment Advisors Inc. ADV Has $7.70 Million Holdings in Danaher Corporation $DHR

Hudson Valley Investment Advisors Inc. ADV lessened its stake in Danaher Corporation (NYSE:DHR) by 16.2% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 38,994 shares of the conglomerate’s stock after selling 7,513 shares during the quarter. Hudson Valley Investment Advisors Inc. ADV’s holdings in Danaher were worth $7,703,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. GHP Investment Advisors Inc. boosted its holdings in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after buying an additional 99 shares during the last quarter. Sierra Ocean LLC boosted its position in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in Danaher during the first quarter worth $31,000. Dunhill Financial LLC boosted its position in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 67 shares during the period. Finally, Costello Asset Management INC bought a new position in Danaher during the first quarter worth $41,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Up 2.2%

DHR opened at $215.05 on Friday. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.41. The company has a 50-day simple moving average of $200.19 and a 200 day simple moving average of $197.42. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $153.98 billion, a price-to-earnings ratio of 45.75, a P/E/G ratio of 3.00 and a beta of 0.77.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. During the same quarter in the prior year, the business posted $1.72 earnings per share. Danaher’s revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio is currently 27.23%.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research analyst reports. Robert W. Baird lifted their price objective on shares of Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a research report on Friday, July 18th. Bank of America reduced their price objective on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research report on Monday, September 22nd. Scotiabank raised shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a research report on Friday, July 11th. Wells Fargo & Company reduced their price objective on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 23rd. Finally, UBS Group reduced their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research report on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $245.91.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 11.10% of the stock is owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.